loading
Precedente Chiudi:
$3.00
Aprire:
$3.35
Volume 24 ore:
407.37K
Relative Volume:
0.94
Capitalizzazione di mercato:
$110.46M
Reddito:
-
Utile/perdita netta:
$-42.94M
Rapporto P/E:
-1.8704
EPS:
-1.62
Flusso di cassa netto:
$-33.64M
1 W Prestazione:
+0.97%
1M Prestazione:
-6.48%
6M Prestazione:
-37.97%
1 anno Prestazione:
-43.08%
Intervallo 1D:
Value
$3.02
$3.35
Intervallo di 1 settimana:
Value
$2.93
$3.35
Portata 52W:
Value
$2.53
$6.85

Pds Biotechnology Corporation Stock (PDSB) Company Profile

Name
Nome
Pds Biotechnology Corporation
Name
Telefono
800-208-3343
Name
Indirizzo
303A COLLEGE ROAD EAST, PRINCETON
Name
Dipendente
25
Name
Cinguettio
@pdsbiotech
Name
Prossima data di guadagno
2024-08-13
Name
Ultimi documenti SEC
Name
PDSB's Discussions on Twitter

Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-11-01 Iniziato B. Riley Securities Buy
2021-06-28 Iniziato Cantor Fitzgerald Overweight
2020-11-10 Aggiornamento H.C. Wainwright Neutral → Buy
2020-05-27 Iniziato Alliance Global Partners Buy
2020-03-09 Iniziato Noble Capital Markets Outperform
2019-10-24 Iniziato Chardan Capital Markets Buy
Mostra tutto

Pds Biotechnology Corporation Borsa (PDSB) Ultime notizie

pulisher
10:01 AM

PDS: Updated Results, VERSATILE-002 Phase 2 Trial - ShareCast

10:01 AM
pulisher
07:31 AM

PDS Biotech Advances with Promising Versamune® HPV Trial Results - TipRanks

07:31 AM
pulisher
07:17 AM

PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024 - StockTitan

07:17 AM
pulisher
Sep 14, 2024

PDS Biotechnology Co. (NASDAQ:PDSB) Receives $14.25 Consensus Target Price from Analysts - MarketBeat

Sep 14, 2024
pulisher
Sep 14, 2024

PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of “Buy” by Brokerages - Defense World

Sep 14, 2024
pulisher
Sep 13, 2024

Aneurysmal Subarachnoid Hemorrhage Drugs Market 95115.59mn Size, Spotlight on Future Potentials (2024-2034) - Talented India

Sep 13, 2024
pulisher
Sep 09, 2024

PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024 - StockTitan

Sep 09, 2024
pulisher
Sep 03, 2024

PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 03, 2024
pulisher
Sep 02, 2024

Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, - openPR

Sep 02, 2024
pulisher
Sep 02, 2024

A History of Outperforming Analyst Forecasts and Beating the Odds: PDS Biotechnology Corporation (PDSB) - SETE News

Sep 02, 2024
pulisher
Aug 23, 2024

Comparing Moolec Science (NASDAQ:MLEC) & Ross Acquisition Corp II (NYSE:ROSS) - Defense World

Aug 23, 2024
pulisher
Aug 23, 2024

Snap-on Incorporated (NYSE:SNA) CFO Aldo John Pagliari Sells 4,473 Shares of Stock - Defense World

Aug 23, 2024
pulisher
Aug 23, 2024

Louisiana-Pacific Co. (NYSE:LPX) CEO William Bradley Southern Sells 32,600 Shares of Stock - Defense World

Aug 23, 2024
pulisher
Aug 23, 2024

Samsara Inc. (NYSE:IOT) Insider John Bicket Sells 78,128 Shares of Stock - Defense World

Aug 23, 2024
pulisher
Aug 22, 2024

PDS Biotechnology (NASDAQ:PDSB) Upgraded to "Strong-Buy" by Alliance Global Partners - MarketBeat

Aug 22, 2024
pulisher
Aug 21, 2024

PDS Biotechnology (NASDAQ:PDSB) Given New $7.00 Price Target at Alliance Global Partners - Defense World

Aug 21, 2024
pulisher
Aug 20, 2024

PDS Biotechnology (NASDAQ:PDSB) Price Target Raised to $7.00 - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

Western Wealth Management LLC Purchases 1,800 Shares of Ares Capital Co. (NASDAQ:ARCC) - Defense World

Aug 20, 2024
pulisher
Aug 20, 2024

Recurrent or Metastatic Head and Neck Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals - openPR

Aug 20, 2024
pulisher
Aug 19, 2024

PDS Biotechnology Co. Forecasted to Earn FY2024 Earnings of ($1.17) Per Share (NASDAQ:PDSB) - MarketBeat

Aug 19, 2024
pulisher
Aug 17, 2024

Aixtron Se (OTCMKTS:AIXXF) Sees Significant Decrease in Short Interest - Defense World

Aug 17, 2024
pulisher
Aug 17, 2024

Vanguard Group Inc. Has $6.23 Million Stock Position in AstroNova, Inc. (NASDAQ:ALOT) - Defense World

Aug 17, 2024
pulisher
Aug 17, 2024

Vanguard Group Inc. Grows Stock Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

PDS Biotechnology Co. Forecasted to Post Q3 2024 Earnings of ($0.28) Per Share (NASDAQ:PDSB) - MarketBeat

Aug 16, 2024
pulisher
Aug 16, 2024

Noble Financial Weighs in on PDS Biotechnology Co.’s Q3 2024 Earnings (NASDAQ:PDSB) - Defense World

Aug 16, 2024
pulisher
Aug 15, 2024

PDS Biotechnology (NASDAQ:PDSB) Posts Earnings Results - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

PDS Biotechnology updates market on new equity sales agreement By Investing.com - Investing.com Australia

Aug 14, 2024
pulisher
Aug 14, 2024

PDS Biotechnology (NASDAQ:PDSB) Announces Earnings Results - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

PDS Biotechnology updates market on new equity sales agreement - Investing.com India

Aug 14, 2024
pulisher
Aug 14, 2024

PDS Biotechnology: Q2 Earnings Snapshot - Darien Times

Aug 14, 2024
pulisher
Aug 14, 2024

NetScientific's PDS Biotech prepares phase 3 trial for VERSATILE-003 - Proactive Investors USA

Aug 14, 2024
pulisher
Aug 14, 2024

NetScientific's PDS Biotech prepares phase 3 trial for VERSATILE-003 - Proactive Investors UK

Aug 14, 2024
pulisher
Aug 14, 2024

PDS Biotechnology: Q2 Earnings Snapshot - New Haven Register

Aug 14, 2024
pulisher
Aug 14, 2024

PDS Biotechnology: Q2 Earnings Snapshot - San Antonio Express-News

Aug 14, 2024
pulisher
Aug 13, 2024

PDS Biotechnology updates market on new equity sales agreement - Investing.com

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology: Q2 Earnings Snapshot - Houston Chronicle

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology updates market on new equity sales agreement By Investing.com - Investing.com UK

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology Enhances and Modulates Stock Sales Agreement - TipRanks

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology: Q2 Earnings Snapshot - San Francisco Chronicle

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - BioSpace

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology: Q2 Earnings Snapshot - Press of Atlantic City

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotech: Business Update and Q2 2024 Results - ShareCast

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology: Q2 Earnings Snapshot - CTPost

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotechnology: Q2 Earnings Snapshot - Greenwich Time

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - wallstreet:online

Aug 13, 2024
pulisher
Aug 13, 2024

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - StockTitan

Aug 13, 2024
pulisher
Aug 09, 2024

PDSBPDS Biotechnology Corporation Latest Stock News & Market Updates - StockTitan

Aug 09, 2024
pulisher
Aug 08, 2024

PDS Biotechnology (PDSB) Set to Announce Earnings on Tuesday - MarketBeat

Aug 08, 2024
pulisher
Aug 08, 2024

PDS Biotechnology (PDSB) Set to Announce Quarterly Earnings on Tuesday - Defense World

Aug 08, 2024
pulisher
Aug 08, 2024

PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting - StockTitan

Aug 08, 2024

Pds Biotechnology Corporation Azioni (PDSB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$26.55
price down icon 1.28%
$196.11
price down icon 1.22%
$28.98
price down icon 9.71%
$69.58
price up icon 1.94%
$127.27
price up icon 3.16%
$538.98
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):